Top

Published in:

01-11-2017 | Point of View

Mother-to-infant transmission of hepatitis B virus: challenges and perspectives

Authors: Yi-Fen Shih, Chun-Jen Liu

Published in: Hepatology International | Issue 6/2017

Abstract

Chronic hepatitis B virus (HBV) infection due to perinatal mother-to-infant transmission (MTIT) remains a serious global health problem. Despite passive-active immunoprophylaxis using hepatitis B vaccination with or without hepatitis B immunoglobulin (HBIg), up to 8–10% of newborns still acquire HBV infection. Understanding the mechanisms of MTIT is essential for the interruption of HBV transmission. There are three possible routes of transmission: intrauterine transmission, transmission during delivery (intrapartum) and postnatal transmission through close contact or breast milk (postpartum). Overall, positivity for hepatitis B e antigen (HBeAg) and the high viral load of the mothers are the two most important risk factors related to MTIT of HBV. This article briefly reviews the viral factors related to MTIT of HBV and discusses the issues that warrant further investigation.

Chen DS. Fighting against viral hepatitis: lessons from Taiwan. Hepatology 2011;54:381–392CrossRefPubMed

World Health Organization. Hepatitis B [updated 2015 Mar]. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/

World Health Organization. Hepatitis B vaccines: WHO position paper. Wkly Epidemiol Rec 2009;84:405–420

Beasley RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol 2009;19:231–234CrossRefPubMed

Cheung KW, Seto MT, Wong SF. Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanismsof in utero infection and the use of antiviral treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2013;169:17–23CrossRefPubMed

Ma L, Alla NR, Li X, et al. Mother-to-child transmission of HBV: review of current clinical management and prevention strategies. Rev Med Virol 2014;24:396–406CrossRefPubMed

Gentile I, Borgia G. Vertical transmission of hepatitis B virus: challenges and solutions. Int J Womens Health 2014;6:605–611PubMedPubMedCentral

Yi P, Chen R, Huang Y, et al. Management of mother-to-child transmission of hepatitis B virus: propositions and challenges. J Clin Virol 2016;77:32–39CrossRefPubMed

Wen WH, Chang MH, Zhao LL, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol 2013;59:24–30CrossRefPubMed

10.

Beasley RP, Trepo C, Stevens CE, et al. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977;105:94–98CrossRefPubMed

11.

Liu CJ, Kao JH. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to. J Semin Liver Dis 2013;33:97–102CrossRefPubMed

12.

Stevens CE, Beasley RP, Tsui J, et al. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771–774CrossRefPubMed

13.

Chen HL, Lin LH, Hu FC, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 2012;142:773–781CrossRefPubMed

14.

Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855–1859CrossRefPubMed

15.

Chen HL, Lee CN, Chang CH, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology 2015;62:375–386CrossRefPubMed

16.

Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 2016;374:2324–2334CrossRefPubMed

17.

Terrault NA, Bzowej NH, Chang KM, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016;63:261–283CrossRefPubMed

18.

Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016;10:1–98CrossRefPubMed

19.

Shi Z, Yang Y, Wang H, et al. Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med 2011;165:837–846CrossRefPubMed

20.

Guo Z, Shi XH, Feng YL, et al. Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women. J Viral Hepat 2013;20:317–321CrossRefPubMed

21.

Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002;67:20–26CrossRefPubMed

22.

Sarin SK, Kumar M, Shrivastava S, et al. Influence of chronic HBV infection on pregnancy: a human model of maternofetal virus host interactions. Gastroenterology 2011;141:1522–1525CrossRefPubMed

23.

Pande C, Sarin SK, Patra S, et al. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat 2013;20:801–810PubMed

24.

Jindal A, Singh A, Sarin SK. Prevention of peripartum hepatitis B transmission. N Engl J Med 2016;375:1496–1497CrossRefPubMed

Title: Mother-to-infant transmission of hepatitis B virus: challenges and perspectives
Authors: Yi-Fen Shih
Chun-Jen Liu
Publication date: 01-11-2017
Publisher: Springer India
Published in: Hepatology International / Issue 6/2017
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI: https://doi.org/10.1007/s12072-017-9831-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Mother-to-infant transmission of hepatitis B virus: challenges and perspectives

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2017

Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey

Improving survival in ACLF: growing evidence for use of G-CSF

AKI persistence at 48 h predicts mortality in patients with acute on chronic liver failure

Primary biliary cholangitis: a comprehensive overview

Second primary cancer after liver transplantation in hepatocellular carcinoma: a nationwide population-based study

Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page